Merck to Settle Canadian Class Action over Vioxx
Merck & Co. has agreed to settle a Canadian class action on the order of $37 million over its blockbuster drug, Vioxx. Vioxx was pulled from the market in September 2004 over concerns that it increased the risk of cardiac complications.
Source: CTV News
About This Site
Canadian Health Law contains updates and articles about the intersection of health and law in Canada. It is written and edited entirely by professionals who work in this area.
The site is edited by Omar Ha-Redeye. For any comments or concerns, please email him at Omar at FleetStreetLaw dot Com.
The site is edited by Omar Ha-Redeye. For any comments or concerns, please email him at Omar at FleetStreetLaw dot Com.